COVID mRNA Vaccines Boost Immunotherapy Effectiveness for Cancer Patients | Federal Cuts to mRNA Vaccine Development Impact Vermont | RFK Jr. Cancels Federal Funding for mRNA Vaccine Development: Experts Warn of Public Health Risks | RFK Jr. Halts $500M Funding for mRNA Vaccine Development, Prioritizes Alternative Strategies | COVID mRNA Vaccines Boost Immunotherapy Effectiveness for Cancer Patients | Federal Cuts to mRNA Vaccine Development Impact Vermont | RFK Jr. Cancels Federal Funding for mRNA Vaccine Development: Experts Warn of Public Health Risks | RFK Jr. Halts $500M Funding for mRNA Vaccine Development, Prioritizes Alternative Strategies
A recent study indicates that mRNA COVID-19 vaccines can significantly enhance the effectiveness of immunotherapy in cancer patients, particularly those with lung cancer and melanoma. The research suggests a potential doubling of survival r...
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Federal cuts to mRNA vaccine development are beginning to impact local manufacturers in Vermont, raising concerns about future pandemic preparedness and the long-term health of the mRNA industry.
Opinion | Jay Bhattacharya: Why the NIH is pivoting away from mRNA vaccines
The decision by Health and Human Services Secretary Robert F. Kennedy Jr. to cancel nearly half a billion dollars in federal funding for mRNA vaccine development has sparked widespread concern among public health experts. This move, impacti...
On Vaccines, Kennedy Has Broken Sharply With the Mainstream
The Department of Health and Human Services (HHS), under the leadership of Secretary Robert F. Kennedy Jr., has announced the cancellation of approximately $500 million in funding for mRNA vaccine development. This decision marks a signific...
RFK Jr. pulls $500 million in funding for vaccine development